ClinicalTrials.gov
ClinicalTrials.gov Menu

Debulking Effect of Curretage on Basal Cell Carcinomas - a Histological Assessment.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00237107
Recruitment Status : Completed
First Posted : October 12, 2005
Last Update Posted : July 19, 2016
Sponsor:
Information provided by (Responsible Party):
Norwegian University of Science and Technology

Brief Summary:
The aim of this study was to compare histologically observed tumour infitration of basal cell carcinoma (bcc) lesions before and after curretage.A significant reduction of tumour depth would enable further bcc's included for superficial non-invasive treatment modalities such as topical photodynamic therapy.

Condition or disease Intervention/treatment Phase
Carcinoma, Basal Cell Procedure: Curretage Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 36 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Official Title: Relation of Basal Cell Carcinoma Tumour Thickness, Histologically Estimated, in Punch Biopsies Performed Before and After Curretage.
Study Start Date : April 2002
Actual Primary Completion Date : December 2004
Actual Study Completion Date : December 2004

Arm Intervention/treatment
Experimental: curettage Procedure: Curretage



Primary Outcome Measures :
  1. Reduction of tumour thickness 0,5mm or more after curretage [ Time Frame: 1 hour ]

Secondary Outcome Measures :
  1. Comparison of tumour thickness in punch biopsies performed on referral, before and after curretage. [ Time Frame: 3 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • bcc with tumour depth two mm.or more

Exclusion Criteria:

  • bcc tumours smaller than three mm in mean diameter.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00237107


Sponsors and Collaborators
Norwegian University of Science and Technology
Investigators
Principal Investigator: Eidi Christensen, MD St. Olav University Hospital, Trondheim

Publications of Results:
Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00237107     History of Changes
Other Study ID Numbers: EC-003
First Posted: October 12, 2005    Key Record Dates
Last Update Posted: July 19, 2016
Last Verified: July 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Norwegian University of Science and Technology:
Cytoreduction Surgical Procedures
Curretage
Photochemotherapy

Additional relevant MeSH terms:
Carcinoma
Carcinoma, Basal Cell
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Basal Cell